SavedAdd your journal

Journals / Retina-Vitreus / 2020 / Cilt: 29 - Sayı: 4

Resolution of Vacuole in Central Serous Chorioretinopathy Following Intravitreal Bevacizumab Injection

Hasan KIZILTOPRAK
Kemal TEKIN
Mustafa KOC
Mehmet Yasin TEKE
Pages
345–351
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

IVB injection may be used as an effective treatment in CSC associated with fi brin accumulation and could have an important role in the resolution of the vacuole sign which consists of fi brin accumulation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We aimed to present a patient with complete resolution of the vacuole sign, which is a previously defi ned optical coherence tomography (OCT) fi nding of central serous chorioretinopathy (CSC), after injection of intravitreal bevazicumab (IVB).
📊
Key Findings & Data:A 38-year old male patient presented with the complaint of decreased vision in the left eye.
💡
Conclusion & Impact:IVB injection may be used as an effective treatment in CSC associated with fi brin accumulation and could have an important role in the resolution of the vacuole sign which consists of fi brin accumulation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

We aimed to present a patient with complete resolution of the vacuole sign, which is a previously defi ned optical coherence tomography (OCT) fi nding of central serous chorioretinopathy (CSC), after injection of intravitreal bevazicumab (IVB). A 38-year old male patient presented with the complaint of decreased vision in the left eye. Fundus examination revealed well-defi ned diffuse serous retinal detachment in the macula of the left eye and the OCT section through that area revealed a serous detachment area, hyper-refl ective fi brinous material accumulation and two vacuolar structures visible as hyporefl ective spaces. In this coexistence of the fi ndings, a recurrent CSC episode accompanied by fi brin accumulation was considered and an IVB injection was performed. One month later, OCT revealed complete resolution of the subretinal fl uid and vacuole sign in addition to irregularities in RPE and the ellipsoid zone. IVB injection may be used as an effective treatment in CSC associated with fi brin accumulation and could have an important role in the resolution of the vacuole sign which consists of fi brin accumulation.

🔖

Cite This Article

KIZILTOPRAK, H., TEKIN, K., KOC, M., TEKE, M. Y. (2020). Resolution of Vacuole in Central Serous Chorioretinopathy Following Intravitreal Bevacizumab Injection. Retina-Vitreus, Cilt: 29 - Sayı: 4, 345–351. https://ajindex.com/articles/299081

References (14)

  1. Daruich A, Matet A, Dirani A, et al. Central serous chorioretinopathy: Recent fi ndings and new physiopathology hypothesis. Prog Retin Eye Res. 2015;15;33-6
  2. Liew G, Quin G, Gillies M, et al. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Experiment Ophthalmol. 2013;41:201-14
  3. Teke MY, Elgin U, Nalcacioglu-Yuksekkaya P, et al. Comparison of autofl uorescence and optical coherence tomography fi ndings in acute and chronic central serouschorioreti nopathy. Int J Ophthalmol. 2014;7:350-4
  4. Tekin K, Colak S, Ozates S, et al. A Rare Optical Coherence Tomography Finding in Central Serous Chorioretinopathy: Vacuole Sign: Case Report. Turkiye Klinikleri J Ophthalmol. Turkiye Klinikleri J Ophthalmol 2018;27:309-13 5. Rajesh B, Kaur A, Giridhar A, et al. ''Vacuole'' Sign Adjacent to Retinal Pigment Epithelial Defects on Spectral Domain Optical Coherence Tomography in Central Serous Chorioretinopathy Associated with Subretinal Fibrin. Retina. 2017;37:316-24
  5. Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature. 2005;437:497-504
  6. Seong HK, Bae JH, Kim ES, et al. Intravitreal bevacizumab to treat acute central serous chorioretinopathy: short-term effect. Ophthalmologica 2009; 223:343-7
  7. Tekin K, Sekeroglu MA, Cankaya AB, et al. Bevacizumab and Ranibizumab in the Treatment of Acute Central Serous Chorioretihopathy: A Single Center Retrospective Study. Semin Ophthalmol. 2016;14:1-6
  8. Ross A, Ross AH, Mohamed Q. Review and update of central serous chorioretinopathy. Curr Opin Ophthalmol 2011;22:166-73
  9. Bujarborua D. Long-term follow-up of idiopathic central serous chorioretinopathy without laser. Acta Ophthalmol Scand. 2001;79:417-21
  10. Hussain N, Bhaskar A, Ram LM, et al. Optical coherence tomographic pattern of fl uorescein angiographic leakage site in acute central serous chorioretinopathy. Clin Exp Opthalmol 2006;34:137-40
  11. Saxena S, Sinha N, Sharma S. Three-dimensional imaging by spectral domain optical coherence tomography in central serous chorioretinopathy with fi brin. J Ocul Biol Dis Infor. 2011;4:149-53
  12. Iacono P, Battaglia Parodi M, et al. Central Serous Chorioretinopathy Treatments: A Mini Review. Ophthalmic Res. 2015;55:76-83
  13. Abouammoh MA. Advances in the treatment of central serous chorioretinopathy. Saudi J Ophthalmol. 2015;29:278-86
  14. Gemenetzi M, De Salvo G, Lotery AJ. Central serous chorioretinopathy: an update on pathogenesis